-
Niagen Bioscience (NASDAQ: NAGE),
formerly ChromaDex, is a
bioscience сompany
based in Los Angeles,
California founded in 1999. The
company operates in...
-
March 2017,
ChromaDex acquired Healthspan Research.
Following the acquisition,
Fried became President and
Chief Operating Officer of
ChromaDex in 2017. In...
-
ChromaDex holds several patents related to
nicotinamide riboside,
including manufacturing methods, compositions, and uses. As of 2025,
ChromaDex's patent...
- eye longevity.
Elysium originally bought the
ingredients in
Basis from
ChromaDex,
which as of
December 2016, sold the two
ingredients to
other supplement...
-
publication and
advertising company in the People's
Republic of China, and
ChromaDex in the
United States. Chau was born in 1961 to a
British Hong Kong small-time...
- 2012). "What Does Gold Bond
Medicated Powder and
Ovaltine Have to Do With
ChromaDex Corp. (CDXC)?
Sanofi SA (SNY) &
Nestle (NSRGY)".
Smallcap Network. Archived...
- Amex).
According to the most
recent SEC Filings, Frost's
ownership in
Chromadex is
about 3.15%,
split between individual ownership and his foundation...
- to its
acquisition by
ChromaDex, and
serves as
member of the
scientific advisory board and
chief scientific advisor to
ChromaDex. 2020, Mary
Swartz Rose...
- Laboratories, Inc. in Smithfield,
North Carolina,
Alkemist Pharmaceuticals,
Chromadex Labs of Irvine, California, and the
University of Mississippi. The American...
-
Boards of the
following companies:
Cocrystal Discovery, Inc (Chairman),
ChromaDex Corporation (Chairman), StemRad, Ltd,
Oplon Ltd (Chairman), and Pacific...
